Related Experiment Video
Updated: Mar 21, 2026
04:50
Author Spotlight: Biological Standardization to Ensure Reproducibility and Harmonization in Research
Published on: August 4, 2023
1.7K
[Anti-platelet aggregation bioassay based quality control for XST capsules].
Summary
A new bioassay method effectively measures the quality control of XST capsules by assessing their anti-platelet aggregation effects. This method demonstrates good repeatability and reliability for XST capsule bioactivity assessment.
Area of Science:
- Pharmacology
- Biotechnology
- Quality Control
Context:
- XST capsules are a traditional medicine requiring robust quality control.
- Platelet aggregation is a key factor in thrombosis and cardiovascular diseases.
- Standardized bioassays are crucial for ensuring the efficacy and safety of pharmaceutical products.
Purpose:
- To develop and validate an in vitro platelet aggregation bioassay for XST capsules.
- To assess the bioactivity and potency of XST capsules.
- To establish a reliable quality control method for XST capsules.
Summary:
- An in vitro platelet aggregation bioassay was developed using rat models to evaluate XST capsules' bioactivity.
- XST capsules demonstrated a dose-dependent inhibition of thrombin-induced platelet aggregation.
- The bioassay showed good repeatability (RSD 2.92%) and reliability, making it suitable for quality control.
Impact:
- This validated bioassay provides a complementary method for ensuring the quality and consistency of XST capsules.
- The findings contribute to the standardization of herbal medicine quality control.
- The study supports the use of XST capsules by providing a reliable method for potency determination.
